Although the vast body of research on Pseudomonas BCAs
deals with their capacity to control soil-borne fungal
pathogens, there has been limited success developing
commercially viable products (see Figure 2 for schematic
diagram depicting requirements for commercial exploitation
of Pseudomonas biocontrol agents).